Boon K, Krab I, Parmeggiani A, Bosch L, Kraal B
Leiden Institute of Chemistry, Gorleaus Laboratories, Department of Biochemistry, The Netherlands.
Eur J Biochem. 1995 Feb 1;227(3):816-22. doi: 10.1111/j.1432-1033.1995.tb20206.x.
Pulvomycin is a strong inhibitor of protein synthesis, known to prevent the binding of aminoacyl-tRNA to elongation factor Tu.GTP (EF-Tu.GTP). Recently, three pulvomycin-resistant mutant strains have been isolated by targeted mutagenesis of the tufA gene resulting in EF-Tu substitutions at positions 230, 333 or 334. In order to analyze the functions of arginine residues located in domain II, with respect to pulvomycin resistance and the interaction with aminoacyl-tRNA, we have investigated the effect of the substitutions of the highly conserved residues Arg230 and Arg233 by site-directed mutagenesis. We have purified two mutants species, [R233S]EF-TuHis and [R230V, R233F]EF-TuHis, both with a C-terminal histidine extension to enable purification by Ni2+ affinity chromatography. In this study, we describe the in vitro characterization of these mutant proteins. The results show that the concomitant substitution of residues at positions 230 and 233, dramatically increases the pulvomycin resistance. Preliminary evidence is presented that protein synthesis is inhibited by an EF-Tu.GDP.pulvomycin complex rather than by EF-Tu.GTP.pulvomycin. Moreover, the mutant [R230V, R233F]EF-TuHis shows a stronger protection of the ester bond of aminoacyl-tRNA than wild-type EF-Tu.
普尔沃霉素是一种强力的蛋白质合成抑制剂,已知它能阻止氨酰 - tRNA与延伸因子Tu·GTP(EF - Tu·GTP)结合。最近,通过对tufA基因进行靶向诱变,分离出了三种对普尔沃霉素耐药的突变菌株,导致EF - Tu在第230、333或334位发生替换。为了分析位于结构域II中的精氨酸残基相对于普尔沃霉素耐药性以及与氨酰 - tRNA相互作用的功能,我们通过定点诱变研究了高度保守的残基Arg230和Arg233替换的影响。我们纯化了两种突变体,[R233S]EF - TuHis和[R230V, R233F]EF - TuHis,两者都有C端组氨酸延伸,以便通过Ni2 +亲和色谱法进行纯化。在本研究中,我们描述了这些突变蛋白的体外特性。结果表明,第230位和233位残基的同时替换显著增加了对普尔沃霉素的耐药性。初步证据表明,蛋白质合成是被EF - Tu·GDP·普尔沃霉素复合物抑制,而不是被EF - Tu·GTP·普尔沃霉素抑制。此外,突变体[R230V, R233F]EF - TuHis对氨酰 - tRNA酯键的保护作用比野生型EF - Tu更强。